top of page
News & Events
May 11, 2026
Frenelle Pharma Announces Advancement Across Pipelines, Validating Hub-and-Spoke
Model
Read Article
May 4, 2026
Frenelle PBC Completes Pharmacokinetic and Toxicology Study with Promising Results
Read Article
April 30, 2026
Frenelle Pharma to Present ARVO 2026 Data on High-Concentration Suprachoroidal Delivery with Faros™ Microspheres
Read Article
April 27, 2026
Anumio Selects Lead Asset for Development Program
Read Article
January 10, 2025
Frenelle Pharma Officially Launches: CEO Missling Attends JPM 2025 Representing Frenelle’s Portfolio
Read Article
November 25, 2024
SpineThera Celebrates Milestone Achievement with 7th Patent Issued by the US Patent and Trademark Office
Read Article
June 17, 2024
SpineThera, Inc. to collaborate with Mayo Clinic to advance solutions in substance abuse disorder treatment
Read Article
May 1, 2024
Anumio has been selected as one of the ten Technology Village Finalists at the upcoming Animal Health, Nutrition and Technology Innovation conference being held Jun 11-13 in Boston, MA
Read Article
April 16, 2024
Anumio is awarded a Launch Minnesota Innovation Grant
Read Article
April 3, 2024
ProMed Pharma Acquires SpineThera Manufacturing Capabilities and an Option to License Intellectual Property
Read Article
October 5, 2023
SpineThera Celebrates Milestone Achievement with 6th Patent Issued by the US Patent and Trademark Office
Read Article
September 25, 2023
SpineThera SALIENT Clinical Trial Results to Be Presented at Upcoming 22nd Annual ASRA Pain Medicine Meeting
Read Article
VIEW OLDER NEWS
Home
About
Technology
Companies
SpineThera
Frenelle PBC
Anumio
Media
Contact
Privacy Policy
Home
About
Technology
Our Companies
SpineThera
Frenelle PBC
Anumio
Media
Contact
Home
About
Technology
Our Companies
SpineThera
Frenelle PBC
Anumio
Media
Contact
bottom of page